6564 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6564)
  2. Epidemiology and Biostatistics (6564)
  3. Department of Medicine (3848)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2487)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1977)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2394)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6564)
  2. Epidemiology and Biostatistics (6564)
  3. Department of Medicine (3848)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2487)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (464)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (118)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6564)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of additional cytogenetic abnormalities and complex karyotype on event-free survival in acute promyelocytic leukemia: Analysis from a single academic center plus the APML4 study
    Meeting Abstract

    Epstein-Peterson, Z. D.; Rajeeve, S.; Derkach, A.; Park, J. H.; Stein, E. M.; Zhang, Y.; Iland, H. J.; Tallman, M. S.
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Initial whole genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Meeting Abstract

    Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; Iacobuzio-Donahue, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Nacev, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Meeting Abstract

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A.; Simone, C. B.; Gelblum, D. Y.; Wu, A. J. C.; Lee, N. Y.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Do differences in the microbiome explain early onset in colon cancer?
    Meeting Abstract

    Keshinro, A.; Vanderbilt, C.; Stadler, Z. K.; Shia, J.; Gonen, M.; Chen, C. T.; Cercek, A.; Mendelsohn, R. B.; Yaeger, R.; Zehir, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Objective and subjective vulvovaginal symptoms in breast cancer patients
    Meeting Abstract

    Goldfarb, S. B.; Saban, S.; Arkema, A.; Patil, S.; Flynn, J.; Goldfrank, D. J.; Norton, L.; Carter, J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save